A Randomized, Open-label, Two-Way Crossover Study to Evaluate Relative Bioavailability and Pharmacodynamics of Two Doses of HSK7653 in Healthy Volunteers
Latest Information Update: 26 Aug 2023
At a glance
- Drugs Cofrogliptin (Primary)
- Indications Glucose intolerance; Renal failure; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Haisco Pharmaceutical Group
Most Recent Events
- 23 Aug 2023 New trial record